Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study.
Iveta MerćepIvana RadmanVladimir TrkuljaTamara BožinaLivija ŠimičevićEma BudimirLana GanociNada BožinaPublished in: European journal of clinical pharmacology (2021)
Loss of function polymorphisms in SLCO1B1 c.521T>C and ABCG2 c.421C>A genes are associated with the presence of rosuvastatin related myotoxicity and/or hepatotoxicity.